FYI - For Your Innovation cover image

Shaping the Immunotherapy Landscape with Patrick Hwu, MD

FYI - For Your Innovation

00:00

How to Accelerate the Cost Declines of Cell Therapy

The timeline for context now is around one to $2 billion and probably it takes from ideation to commercialization something like 10 years. One of the things that would help sort of the pricing debate, but also maybe even accelerate these approvals is these cost declines. And we think CRISPR is helping both from preclinical screen perspective, but we also think it could command premium pricing because it's potentially curative. Some of these cell therapies may also command sub premium pricing.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app